march call put ratio exceptionally bullish. last I heard, short interst is still around 20%. the shorts are battling to keep this as low as possible. it apprears to me that the shorts have fewer bullsets than those owning calls. watch for volumne to double into next week as these two positions battle each other.
Better read the scriptures Michelle your Savior said " call no man a fool or you shall be in danger of hell fire" It also says do unto others as you would have them do unto you, you and garvey and many on this board need to start doing that are you will strongly regret it one day.
I'm not sure how to phrase this question, but I'll give it a try. Are you saying that there are approximately an equal or greater number of call contracts at the March 7.5s and 10s to do battle with over 6 million short shares? Thanks.
truthfully, I don't know who has the most bullets at this point. However, I watch fast money every day and the traders definitely follow the put/call ratio more than short interest. that being said, I am very long (will hold/add until their is some final determination from the FDA). I have worked in pharma for 25 years and have NEVER seen phase II results as strong as they reported. I also have had interactions with FDA scientists over the years. I am sure they audited the #$%$ out of the phase II data. the results of those audits/interviews resulted in a suggested change to their phase III protocol which basically admitted that this drug conjugate is better than existing non-conjugate therapy. the question is, how many cycles of the conjugate therapy be applied to cancer patients prior to evidence of losing efficacy, or an increase in side effects. my opinion, do your own due diligence. that being said, try to pay no attention to bloggers named big #$%$ or big black. they are uncredible. good luck.